Free Newsletter
FEATURES >> The most interesting logos in Pharma
GSK pulls app for preventive Avodart use
GlaxoSmithKline said it would temporarily withdraw its application to expand use of Avodart--which is approved to treat symptoms of an enlarged prostate--to include cancer prevention. Report
Comments
Very interesting and informative article indeed. I have to admit that I have not known that GlaxoSmithKline decided to withdraw its application to expand use of Avodart. Personally I think that it is really a great and smart decision and this will be very effective in the future. I always follow your website because I always find there something interesting and new about various subjects. Thanks a lot for the interesting information and I will definitely try to find more information about this subject. Keep up publishing those great articles by the way.
Regards, Lenny Watson from iphone application development
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
SHARE
WITH: